Under the category of the OTC/Nutraceutical products are listed the products which are sold without prescription. Members of Farmavita.net are invited to publish their out-license offers in this Category.

Irbesartan-hydrochlorothiazide

Popular

Description

There is on-going development of generic EU CTD Dossier of Irbesartan-hydrochlorothiazide, filmcoated tablets, 150+12.5/300+12.5 mg.

Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

As with all angiotensin II receptor antagonists, irbesartan is indicated for the treatment of hypertension. Irbesartan may also delay progression of diabetic nephropathy and is also indicated for the reduction of renal disease progression in patients with type 2 diabetes,[1] hypertension and microalbuminuria (>30 mg/24 hours) or proteinuria (>900 mg/24 hours).

Irbesartan is also available in a combination formulation with a low dose thiazide diuretic, invariably hydrochlorothiazide, to achieve an additive antihypertensive effect. Irbesartan/hydrochlorothiazide combination preparations are marketed under similar trade names to irbesartan preparations, including Irda, CoIrda, CoAprovel, Karvezide, Avalide and Avapro HCT.

More details at: http://www.rxlist.com/avalide-drug.htm.

More details

Name Description
Pharma licensing Out-licensing (offer)

Ad details

Ad ID : 591

Advertiser details

Contact Advertiser

Add comment

 
 

Contact form

Sorry, you need to register or login first.

What's wrong with this ad?

Sorry, you need to register or login first.

Add to favourites

Sorry, you need to register or login first.

Advert search

Recent adverts

Start-up pharmaceutical company from South...
175 Views
Member of Farmavita.net is looking to...
288 Views
I want to give process knowhow and NON GMO...
n/a
809 Views
OUT-LICENSING HYBRID DOSSIER OF ALIMEMAZINE...
1066 Views
 Company portfolio: Manufacturing over 100...
1417 Views
Objective: To enter into EU domain procuring...
1195 Views
Objective: To enter into EU domain grabbing a...
949 Views